Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease
- PMID: 38961767
- DOI: 10.1002/jmv.29781
Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease
Abstract
Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a serious and common extra-articular disease manifestation. Patients with RA-ILD experience reduced bacterial diversity and gut bacteriome alterations. However, the gut mycobiome and virome in these patients have been largely neglected. In this study, we performed whole-metagenome shotgun sequencing on fecal samples from 30 patients with RA-ILD, and 30 with RA-non-ILD, and 40 matched healthy controls. The gut bacteriome and mycobiome were explored using a reference-based approach, while the gut virome was profiled based on a nonredundant viral operational taxonomic unit (vOTU) catalog. The results revealed significant alterations in the gut microbiomes of both RA-ILD and RA-non-ILD groups compared with healthy controls. These alterations encompassed changes in the relative abundances of 351 bacterial species, 65 fungal species, and 4,367 vOTUs. Bacteria such as Bifidobacterium longum, Dorea formicigenerans, and Collinsella aerofaciens were enriched in both patient groups. Ruminococcus gnavus (RA-ILD), Gemmiger formicilis, and Ruminococcus bromii (RA-non-ILD) were uniquely enriched. Conversely, Faecalibacterium prausnitzii, Bacteroides spp., and Roseburia inulinivorans showed depletion in both patient groups. Mycobiome analysis revealed depletion of certain fungi, including Saccharomyces cerevisiae and Candida albicans, in patients with RA compared with healthy subjects. Notably, gut virome alterations were characterized by an increase in Siphoviridae and a decrease in Myoviridae, Microviridae, and Autographiviridae in both patient groups. Hence, multikingdom gut microbial signatures showed promise as diagnostic indicators for both RA-ILD and RA-non-ILD. Overall, this study provides comprehensive insights into the fecal virome, bacteriome, and mycobiome landscapes of RA-ILD and RA-non-ILD gut microbiota, thereby offering potential biomarkers for further mechanistic and clinical research.
Keywords: gut microbiota; gut virome; interstitial lung disease; microbiota dysbiosis; rheumatoid arthritis; whole‐metagenome shotgun sequencing.
© 2024 Wiley Periodicals LLC.
Similar articles
-
Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis.Microbiol Spectr. 2023 Feb 14;11(1):e0171122. doi: 10.1128/spectrum.01711-22. Epub 2022 Dec 14. Microbiol Spectr. 2023. PMID: 36515546 Free PMC article.
-
Characterizations of the multi-kingdom gut microbiota in Chinese patients with gouty arthritis.BMC Microbiol. 2023 Nov 24;23(1):363. doi: 10.1186/s12866-023-03097-0. BMC Microbiol. 2023. PMID: 38001408 Free PMC article.
-
Metagenomic analysis of the gut virome in patients with irritable bowel syndrome.J Med Virol. 2024 Jul;96(7):e29802. doi: 10.1002/jmv.29802. J Med Virol. 2024. PMID: 39023095
-
Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis.Front Endocrinol (Lausanne). 2023 Jan 9;13:1044673. doi: 10.3389/fendo.2022.1044673. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36699026 Free PMC article. Review.
-
Roles of the gut virome and mycobiome in faecal microbiota transplantation.Lancet Gastroenterol Hepatol. 2022 May;7(5):472-484. doi: 10.1016/S2468-1253(21)00303-4. Epub 2022 Mar 8. Lancet Gastroenterol Hepatol. 2022. PMID: 35276080 Review.
Cited by
-
Gut Dysbiosis and Dietary Interventions in Rheumatoid Arthritis-A Narrative Review.Nutrients. 2024 Sep 23;16(18):3215. doi: 10.3390/nu16183215. Nutrients. 2024. PMID: 39339815 Free PMC article. Review.
References
REFERENCES
-
- Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360‐1372. doi:10.1001/jama.2018.13103
-
- Cassone G, Manfredi A, Vacchi C, et al. Treatment of rheumatoid Arthritis‐Associated interstitial lung disease: lights and shadows. J Clin Med. 2020;9(4):1082. doi:10.3390/jcm9041082
-
- Kakutani T, Hashimoto A, Tominaga A, et al. Related factors, increased mortality and causes of death in patients with rheumatoid arthritis‐associated interstitial lung disease. Modern Rheumatol. 2020;30(3):458‐464. doi:10.1080/14397595.2019.1621462
-
- Izuka S, Yamashita H, Iba A, Takahashi Y, Kaneko H. Acute exacerbation of rheumatoid arthritis‐associated interstitial lung disease: clinical features and prognosis. Rheumatology. 2021;60(5):2348‐2354. doi:10.1093/rheumatology/keaa608
-
- Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis‐associated interstitial lung disease. Eur Respir J. 2010;35(6):1322‐1328. doi:10.1183/09031936.00092309
MeSH terms
Grants and funding
- Dalian Key Laboratory for Autoantibody Testing
- JCH22023017/Interdisciplinary Research Cooperation Project Team Funding of Dalian Medical University
- 82225048/National Natural Science Foundation of China
- XJ2023001102/The cultivating scientific research project of the Second Hopital of Dalian Medical University
- Liaoning Province Key Clinical Specialized (Department of Rheumatology, the Second Affiliated Hospital of Dalian Medical University) Funds
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous